These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4150247)

  • 1. Microassay of tyrosine-amino transferase and p-hydroxyphenylpyruvic acid oxidase in mammalian liver and patients with hereditary tyrosinemia.
    Whelan DT; Zannoni VG
    Biochem Med; 1974 Jan; 9(1):19-31. PubMed ID: 4150247
    [No Abstract]   [Full Text] [Related]  

  • 2. Tyrosinosis (tyrosinaemia).
    Jaiswal RB
    Indian Pediatr; 1975 Mar; 12(3):209-10. PubMed ID: 239906
    [No Abstract]   [Full Text] [Related]  

  • 3. Enzyme defect in a case of tyrosinemia type I, acute form.
    Furukawa N; Kinugasa A; Seo T; Ishii T; Ota T; Machida Y; Inoue F; Imashuku S; Kusunoki T; Takamatsu T
    Pediatr Res; 1984 May; 18(5):463-6. PubMed ID: 6145143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new variant form of hypertyrosinaemia due to 4-hydroxyphenylpyruvic acid oxidase deficiency.
    Endo F; Kitano A; Uehara I; Nagata N; Matsuda I; Shinka T; Kuhara T; Matsumoto I
    J Inherit Metab Dis; 1982; 5(4):237-8. PubMed ID: 6133038
    [No Abstract]   [Full Text] [Related]  

  • 5. Enzymatic studies in a case of hereditary tyrosinemia with hepatoma.
    Gentz J; Heinrich J; Lindblad B; Lindstedt S; Zetterström R
    Acta Paediatr Scand; 1969 Jul; 58(4):393-6. PubMed ID: 4390478
    [No Abstract]   [Full Text] [Related]  

  • 6. The enzymatic deficiency in tyrosinemia.
    La Du BN
    Am J Dis Child; 1967 Jan; 113(1):54-7. PubMed ID: 4380967
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical observations on so-called hereditary tyrosinemia.
    Gaull GE; Rassin DK; Solomon GE; Harris RC; Sturman JA
    Pediatr Res; 1970 Jul; 4(4):337-44. PubMed ID: 4393588
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of acetoacetate on tyrosine metabolism in guinea-pigs fed a scorbutic diet.
    Bhai I; Reddi TG; Nath MC
    Indian J Biochem; 1970 Mar; 7(1):40-1. PubMed ID: 4394028
    [No Abstract]   [Full Text] [Related]  

  • 9. Tyrosine toxicity in the rat: effect of high intake of p-hydroxyphenylpyruvic acid and of force-feeding high tyrosine diet.
    Boctor AM; Harper AE
    J Nutr; 1968 Aug; 95(4):535-40. PubMed ID: 4385833
    [No Abstract]   [Full Text] [Related]  

  • 10. New forms of hereditary tyrosinemia type II in mink: hepatic tyrosine aminotransferase defect.
    Christensen K; Henriksen P; Sørensen H
    Hereditas; 1986; 104(2):215-22. PubMed ID: 2876972
    [No Abstract]   [Full Text] [Related]  

  • 11. Assay, properties and tissue distribution of p-hydroxyphenylpyruvate hydroxylase.
    Fellman JH; Fujita TS; Roth ES
    Biochim Biophys Acta; 1972 Sep; 284(1):90-100. PubMed ID: 4627454
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative study of 3 liver enzymes metabolising tyrosine in vertebrates during evolution (tyrosine alpha-ketoglutarate aminotransferase, parahydfoxphenylpyruvate hydroxlyase, homogentisate oxygenase].
    Goswami MN; Rosenberg AJ
    C R Acad Hebd Seances Acad Sci D; 1968 Dec; 267(25):2224-7. PubMed ID: 4387481
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatic tyrosine aminotransferase in tyrosinaemia type II.
    Kida K; Takahashi M; Fujisawa Y; Matsuda H; Machino H; Miki Y
    J Inherit Metab Dis; 1982; 5(4):229-30. PubMed ID: 6133036
    [No Abstract]   [Full Text] [Related]  

  • 14. Soluble and mitochondrial forms of tyrosine aminotransferase. Relationship to human tyrosinemia.
    Fellman JH; Vanbellinghen PJ; Jones RT; Koler RD
    Biochemistry; 1969 Feb; 8(2):615-22. PubMed ID: 4389443
    [No Abstract]   [Full Text] [Related]  

  • 15. Defect in soluble tyrosine aminotransferase in skin fibroblasts of a patient with tyrosinemia.
    deGroot GW; Dakshinamurti K; Allan L; Haworth JC
    Pediatr Res; 1980 Jul; 14(7):896-8. PubMed ID: 6106182
    [No Abstract]   [Full Text] [Related]  

  • 16. The enzyme defects in hereditary tyrosinaemia type I.
    Furukawa N; Hayano T; Sato N; Inoue F; Machida Y; Kinugasa A; Imashuku S; Kusunoki T; Takamatisu T
    J Inherit Metab Dis; 1984; 7 Suppl 2():137-8. PubMed ID: 6434869
    [No Abstract]   [Full Text] [Related]  

  • 17. The origin of urinary p-hydroxyphenylpyruvate in a patient with hepatic cytosol tyrosine aminotransferase deficiency.
    Kennaway NG; Buist NR; Fellman JH
    Clin Chim Acta; 1972 Oct; 41():157-61. PubMed ID: 4405100
    [No Abstract]   [Full Text] [Related]  

  • 18. Hereditary tyrosinemia: metabolic studies in a patient with partial p-hydroxyphenylpyruvate hydroxylase activity.
    Jagenburg R; Landblad B; De Maré JM; Rödjer S
    J Pediatr; 1972 Jun; 80(6):994-1004. PubMed ID: 5026040
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful dietary control of tyrosinemia II.
    Machino H; Miki Y; Kawatsu T; Kida K; Matsuda H
    J Am Acad Dermatol; 1983 Oct; 9(4):533-9. PubMed ID: 6195199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transitory hypertyrosinemia of young infants and its relation to vitamin C].
    Henze H; Bremer HJ
    Monatsschr Kinderheilkd (1902); 1969 Jun; 117(6):433-6. PubMed ID: 4393253
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.